- Home
- ATNM vs MLSS Comparison
ATNM vs MLSS Comparison
Compare ATNM & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- MLSS
- Stock Information
- Founded
- ATNM 2000
- MLSS 1989
- Country
- ATNM United States
- MLSS United States
- Employees
- ATNM N/A
- MLSS N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- MLSS Industrial Specialties
- Sector
- ATNM Health Care
- MLSS Health Care
- Exchange
- ATNM Nasdaq
- MLSS Nasdaq
- Market Cap
- ATNM 50.2M
- MLSS 42.4M
- IPO Year
- ATNM N/A
- MLSS 1995
- Fundamental
- Price
- ATNM $1.63
- MLSS $0.59
- Analyst Decision
- ATNM Strong Buy
- MLSS Buy
- Analyst Count
- ATNM 2
- MLSS 1
- Target Price
- ATNM $4.50
- MLSS $1.25
- AVG Volume (30 Days)
- ATNM 130.6K
- MLSS 57.3K
- Earning Date
- ATNM 11-13-2025
- MLSS 11-13-2025
- Dividend Yield
- ATNM N/A
- MLSS N/A
- EPS Growth
- ATNM N/A
- MLSS N/A
- EPS
- ATNM N/A
- MLSS N/A
- Revenue
- ATNM N/A
- MLSS $9,083,205.00
- Revenue This Year
- ATNM N/A
- MLSS $17.24
- Revenue Next Year
- ATNM N/A
- MLSS $14.58
- P/E Ratio
- ATNM N/A
- MLSS N/A
- Revenue Growth
- ATNM N/A
- MLSS 7.84
- 52 Week Low
- ATNM $1.03
- MLSS $0.38
- 52 Week High
- ATNM $2.41
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- ATNM 46.73
- MLSS 46.41
- Support Level
- ATNM $1.52
- MLSS $0.55
- Resistance Level
- ATNM $1.70
- MLSS $0.65
- Average True Range (ATR)
- ATNM 0.07
- MLSS 0.04
- MACD
- ATNM -0.01
- MLSS -0.00
- Stochastic Oscillator
- ATNM 36.71
- MLSS 38.90
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.